Skip to main content

Table 1 Participant demographics round 1–3

From: A modified Delphi study to identify screening items to assess neglected sexual side-effects following prostate cancer treatment

Participant demographics

Round 1

Round 2

Round 3

Number

27

23

20

Age

   

31–40

5 (19%)

3 (13%)

2 (10%)

41–50

11 (41%)

9 (39%)

8 (40%)

51–60

8 (30%

8 (35%)

8 (40%)

 > 61

3 (11%)

3 (13%)

2 (10%)

Gender

   

Male

13 (48%)

11 (48%)

9 (45%)

Female

14 (52%)

12 (52%)

11 (55%)

Profession

   

Oncologist

4 (15%)

3 (13%)

2 (10%)

Physiotherapist

6 (22%)

5 (22%)

5 (25%)

Psychologist

2 (7%)

2 (9%)

2 (10%)

Sexologist (with a medical background i.e. a GP)

3 (11%)

3 (13%)

2 (10%)

Sexologist (with a psychology background)

4 (15%)

4 (17%)

4 (20%)

Urologist (involved in brachytherapy/radiation therapy)

3 (11%)

2 (9%)

2 (10%)

Urologist (performing radical prostatectomies)

5 (19%)

4 (17%)

3 (15%)

Highest academic qualification

   

Bachelor’s degree

3 (11%)

2 (9%)

2 (10%)

Honours degree

3 (11%)

2 (9%)

2 (10%)

Master’s degree

15 (56%)

13 (57%)

11 (55%)

PhD

6 (22%)

6 (26%)

5 (25%)

Health sector

   

Government

1 (4%)

1 (4%)

1 (5%)

Private

20 (74%)

17 (74%)

15 (75%)

Private, govt and academic

2 (7%)

2 (9%)

2 (10%)

Private and academic

4 (15%)

3 (13%)

2 (10%

Years of experience

   

 < 5 years

1 (4%)

  

5–10 years

4 (15%)

4 (17%)

3 (15%)

11–15 years

4 (15%)

4 (17%)

3 (15%)

16–20 years

6 (22%)

3 (13%)

3 (15%)

 > 20 years

12 (44%)

12 (52%)

11 (55%)